Oldstone, M. B. A. Viruses, Plagues and History (Oxford University Press, New York, 1998). Google Scholar
Whitton, J. L. & Oldstone, M. B. A. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 285–320 (Lippincott Williams, Philadelphia, 2001). Google Scholar
Zinkernagel, R. M. Maternal antibodies, childhood infections and autoimmune diseases. N. Engl. J. Med.345, 1331–1335 (2001). ArticleCASPubMed Google Scholar
Koff, W. C. & Fauci, A. S. Human trials of AIDS vaccines: current status and future directions. AIDS3, S125–S129 (1989). ArticlePubMed Google Scholar
Cohen, J. AIDS research. Merck reemerges with a bold AIDS vaccine effort. Science292, 24–25 (2001). ArticleCASPubMed Google Scholar
McMichael, A. & Hanke, T. The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible? Nature Rev. Immunol.2, 283–291 (2002). ArticleCAS Google Scholar
Robinson, H. L. New hope for an AIDS vaccine. Nature Rev. Immunol.2, 239–250 (2002). ArticleCAS Google Scholar
Letvin, N. L., Barouch, D. H. & Montefiori, D. C. Prospects for vaccine protection against HIV-1 infection and AIDS. Annu. Rev. Immunol.20, 73–99 (2002). ArticleCASPubMed Google Scholar
Dimmock, N. J. Update on the neutralization of animal viruses. Rev. Med. Virol.5, 165–179 (1995). Article Google Scholar
Burnet, F. M., Keogh, E. V. & Lush, D. The immunological reactions of the filterable viruses. Austral. J. Exp. Biol. Med. Sci.15, 231–368 (1937). CAS Google Scholar
Spear, G. T., Hart, M., Olinger, G. G., Hashemi, F. B. & Saifuddin, M. The role of the complement system in virus infections. Curr. Top. Microbiol. Immunol.260, 229–245 (2001). CASPubMed Google Scholar
McCullough, K. C., Parkinson, D. & Crowther, J. R. Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology65, 187–191 (1988). CASPubMedPubMed Central Google Scholar
Fujinami, R. S. & Oldstone, M. B. Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature279, 529–530 (1979). ArticleCASPubMed Google Scholar
Levine, B. et al. Antibody-mediated clearance of alphavirus infection from neurons. Science254, 856–860 (1991). ArticleCASPubMed Google Scholar
Gerhard, W. The role of the antibody response in influenza virus infection. Curr. Top. Microbiol. Immunol.260, 171–190 (2001). CASPubMed Google Scholar
Pantaleo, G. et al. Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission. Eur. J. Immunol.25, 226–231 (1995). ArticleCASPubMed Google Scholar
Burioni, R., Williamson, R. A., Sanna, P. P., Bloom, F. E. & Burton, D. R. Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro. Proc. Natl Acad. Sci. USA91, 355–359 (1994). ArticleCASPubMedPubMed Central Google Scholar
Hooks, J. J., Burns, W., Hayashi, K., Geis, S. & Notkins, A. L. Viral spread in the presence of neutralization antibody: mechanisms of persistence in foamy virus infection. Infect. Immun.14, 1172–1178 (1976). CASPubMedPubMed Central Google Scholar
Hezareh, M., Hessell, A. J., Jensen, R., van de Winkel, J. G. J. & Parren, P. W. H. I. Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1. J. Virol.75, 12161–12168 (2001). ArticleCASPubMedPubMed Central Google Scholar
Henchal, E. A., Henchal, L. S. & Schlesinger, J. J. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J. Gen. Virol.69, 2101–2107 (1988). ArticlePubMed Google Scholar
Manzanec, M. B., Lamm, M. E., Lyn, D., Porter, A. & Bedrud, J. G. Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus. Res.23, 1–12 (1992). Article Google Scholar
Fujioka, H. et al. Immunocytochemical colocalization of specific immunoglobulin A with sendai virus protein in infected polarized epithelium. J. Exp. Med.188, 1223–1229 (1998). ArticleCASPubMedPubMed Central Google Scholar
Manzanec, M. B., Coudret, C. L. & Fletcher, D. R. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J. Virol.69, 1339–1343 (1995). Google Scholar
Kato, H., Kato, R., Fujihashi, K. & McGhee, J. R. Role of mucosal antibodies in viral infections. Curr. Top. Microbiol. Immunol.260, 201–228 (2001). CASPubMed Google Scholar
Bomsel, M. et al. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dlgA or IgM. Immunity9, 277–287 (1998). ArticleCASPubMed Google Scholar
Hawkes, R. A. & Lafferty, K. J. The enhancement of virus infectivity by antibody. Virology33, 250–261 (1967). ArticleCASPubMed Google Scholar
Halstead, S. B. Immune enhancement of viral infection. Prog. Allergy31, 301–364 (1982). CASPubMed Google Scholar
Morens, D. M., Halstead, S. B. & Marchette, N. J. Profiles of antibody-dependent enhancement of dengue virus type 2 infection. Microb. Pathog.3, 231–237 (1987). ArticleCASPubMed Google Scholar
Sullivan, N., Sun, Y., Li, J., Hofmann, W. & Sodroski, J. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell-line-passaged human immunodeficiency virus type 1 isolates. J. Virol.69, 4413–4422 (1995). CASPubMedPubMed Central Google Scholar
Sullivan, N. J. Antibody-mediated enhancement of viral disease. Curr. Top. Microbiol. Immunol.260, 145–169 (2001). CASPubMed Google Scholar
Kliks, S. C., Nimmanitya, S., Nisalak, A. & Burke, D. S. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg.38, 411–419 (1988). ArticleCASPubMed Google Scholar
Prince, G. A., Horswood, R. L. & Chanock, R. M. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J. Virol.55, 517–520 (1985). CASPubMedPubMed Central Google Scholar
Parren, P. W. H. I. et al. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol.75, 8340–8347 (2001). ArticleCASPubMedPubMed Central Google Scholar
Nishimura, Y. et al. Determination of a statistically valid neutralization titer in plasma that confers protection against simian–human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J. Virol.76, 2123–2130 (2002). ArticleCASPubMedPubMed Central Google Scholar
Wright, K. E. & Buchmeier, M. J. Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection. J. Virol.65, 3001–3006 (1991). CASPubMedPubMed Central Google Scholar
Parren, P. W. H. I., Geisbert, T. W., Maruyama, T., Jahrling, P. B. & Burton, D. R. Pre- and postexposure prophylaxis of ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J. Virol.76, 6408–6412 (2002). ArticleCASPubMedPubMed Central Google Scholar
Schlesinger, J. J. & Chapman, S. Neutralizing F(ab′)2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fails to protect mice against lethal YF encephalitis. J. Gen. Virol.76, 217–220 (1995). ArticleCASPubMed Google Scholar
Chanock, R. M., Crowe, J. E. Jr, Murphy, B. R. & Burton, D. R. Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases. Infect. Agents Dis.2, 118–131 (1993). CASPubMed Google Scholar
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.. Pediatrics102, 531–537 (1998).
Ogra, P. L., Faden, H. & Welliver, R. C. Vaccination strategies for mucosal immune responses. Clin. Microbiol. Rev.14, 430–445 (2001). ArticleCASPubMedPubMed Central Google Scholar
Burns, J. W., Siadat-Pajouh, M., Krishnaney, A. A. & Greenberg, H. G. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science272, 104–107 (1996). ArticleCASPubMed Google Scholar
Jin, X. et al. Dramatic rise in plasma viremia after CD8+ T-cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med.189, 991–998 (1999). ArticleCASPubMedPubMed Central Google Scholar
Schmitz, J. E. et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science283, 857–860 (1999). ArticleCASPubMed Google Scholar
Kaech, S. M., Wherry, E. J. & Ahmed, R. Effector and memory T-cell differentiation: implications for vaccine development. Nature Rev. Immunol.2, 251–262 (2002). ArticleCAS Google Scholar
McMichael, A. J. & Rowland-Jones, S. L. Cellular immune responses to HIV. Nature410, 980–987 (2001). ArticleCASPubMed Google Scholar
Barouch, D. H. & Letvin, N. L. CD8+ cytotoxic T-lymphocyte responses to lentiviruses and herpesviruses. Curr. Opin. Immunol.13, 479–482 (2001). ArticleCASPubMed Google Scholar
Alexander-Miller, M. A., Leggatt, G. R. & Berzofsky, J. A. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl Acad. Sci. USA93, 4102–4107 (1996). ArticleCASPubMedPubMed Central Google Scholar
Slifka, M. K. & Whitton, J. L. Functional avidity maturation of CD8+ T cells without selection of higher affinity TCR. Nature Immunol.2, 711–717 (2001). ArticleCAS Google Scholar
Picker, L. J. & Maino, V. C. The CD4+ T-cell response to HIV-1. Curr. Opin. Immunol.12, 381–386 (2000). ArticleCASPubMed Google Scholar
Kalams, S. A. & Walker, B. D. The critical need for CD4 help in maintaining effective cytotoxic T-lymphocyte responses. J. Exp. Med.188, 2199–2204 (1998). ArticleCASPubMedPubMed Central Google Scholar
Hasenkrug, K. J. & Chesebro, B. Immunity to retroviral infection: the Friend virus model. Proc. Natl Acad. Sci. USA94, 7811–7816 (1997). ArticleCASPubMedPubMed Central Google Scholar
Dittmer, U., Brooks, D. M. & Hasenkrug, K. J. Requirement for multiple lymphocyte subsets in protection by a live-attenuated vaccine against retroviral infection. Nature Med.5, 189–193 (1999). ArticleCASPubMed Google Scholar
Dittmer, U. & Hasenkrug, K. J. Different immunological requirements for protection against acute versus persistent friend retrovirus infections. Virology272, 177–182 (2000). ArticleCASPubMed Google Scholar
Slifka, M. K. & Ahmed, R. Long-term humoral immunity against viruses: revisiting the issue of plasma-cell longevity. Trends Microbiol.4, 394–400 (1996). ArticleCASPubMedPubMed Central Google Scholar
Slifka, M. K. & Ahmed, R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr. Opin. Immunol.10, 252–258 (1998). ArticleCASPubMed Google Scholar
Ochsenbein, A. F. et al. Protective long-term antibody memory by antigen-driven and T-help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc. Natl Acad. Sci. USA97, 13263–13268 (2000). ArticleCASPubMedPubMed Central Google Scholar
Janeway, C. A. Use of concentrated human serum γ-globulin in the prevention and attenuation of measles. NY Acad. Med.21, 202 (1945). CAS Google Scholar
Copelovici, Y., Strulovici, D., Cristea, A. L., Tudor, V. & Armasu, V. Data on the efficiency of specific antimumps immunoglobulins in the prevention of mumps and of its complications. Virologie30, 171–177 (1979). CASPubMed Google Scholar
Martin du Pan, R., Koechli, B. & Douath, A. Protection of nonimmune volunteers against rubella by intravenous administration of normal human γ-globulin. J. Infect. Dis.126, 341–344 (1972). ArticleCASPubMed Google Scholar
Balfour, H. H. Jr et al. Prevention or modification of varicella using zoster-immune plasma. Am. J. Dis. Child.131, 693–696 (1977). PubMed Google Scholar
Kreil, T. R., Maier, E., Fraiss, S. & Eibl, M. M. Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein. J. Virol.72, 3076–3081 (1998). CASPubMedPubMed Central Google Scholar
Good, R. A. & Zak, S. Z. Disturbance in γ-globulin synthesis as 'experiments of nature'. Pediatrics18, 109–149 (1956). CASPubMed Google Scholar
Sanna, P. P. & Burton, D. R. Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts. J. Virol.74, 9813–9817 (2000). ArticleCASPubMedPubMed Central Google Scholar
Klavinskis, S., Oldstone, M. B. A. & Whitton, J. L. in Vaccines 89. Modern Approaches to New Vaccines Including Prevention of AIDS (eds Brown, F., Chanock, R., Ginsberg, H. & Lerner, R.) 485–489 (Cold Spring Harbor Laboratory Press, 1989). Google Scholar
Ulmer, J. B. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science259, 1745–1749 (1993). ArticleCASPubMed Google Scholar
Kulkarni, A. B. et al. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J. Virol.69, 1261–1264 (1995). CASPubMedPubMed Central Google Scholar
Hislop, A. D. et al. Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge. Nature Med.4, 1193–1196 (1998). ArticleCASPubMed Google Scholar
Mateo, L., Gardner, J. & Suhrbier, A. Delayed emergence of bovine leukemia virus after vaccination with a protective cytotoxic T-cell-based vaccine. AIDS Res. Hum. Retroviruses17, 1447–1453 (2001). ArticleCASPubMed Google Scholar
Shiver, J. W. et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature415, 331–335 (2002). ArticleCASPubMed Google Scholar
Allen, T. M. et al. Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication. J. Virol.76, 4108–4112 (2002). ArticleCASPubMedPubMed Central Google Scholar
Bachmann, M. F. & Zinkernagel, R. M. The influence of virus structure on antibody responses and virus serotype formation. Immunol. Today17, 553–558 (1996). ArticleCASPubMed Google Scholar
Bachmann, M. F. & Zinkernagel, R. M. Neutralizing antiviral B-cell responses. Annu. Rev. Immunol.15, 235–270 (1997). ArticleCASPubMed Google Scholar
Roben, P. et al. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J. Virol.68, 4821–4828 (1994). CASPubMedPubMed Central Google Scholar
Sattentau, Q. J. & Moore, J. P. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med.182, 185–196 (1995). ArticleCASPubMed Google Scholar
Sakurai, H. et al. Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines. J. Virol.73, 2956–2962 (1999). CASPubMedPubMed Central Google Scholar
Moore, J. P. & Ho, D. D. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS9, S117–S136 (1995). PubMed Google Scholar
Parren, P. W. H. I., Sattentau, Q. J. & Burton, D. R. HIV-1 antibody – debris or virion? Nature Med.3, 366–367 (1997). ArticleCASPubMed Google Scholar
Burton, D. R. & Parren, P. W. H. I. Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection? Nature Med.6, 123–125 (2000). ArticleCASPubMed Google Scholar
Francis, T. Jr. Influenza: the newe acquayantance. Ann. Int. Med.39, 203–221 (1953). ArticlePubMed Google Scholar
Davenport, F. M. & Hennessy, A. V. Predetermination by infection and by vaccination of antibody response to influenza virus vaccines. J. Exp. Med.106, 835–850 (1957). ArticleCASPubMedPubMed Central Google Scholar
Fazekas de St. Groth, S. & Webster, R. G. Disquisitions on original antigenic sin. I. Evidence in man. J. Exp. Med.124, 331–345 (1966). ArticleCASPubMed Google Scholar
East, I. J., Todd, P. E. & Leach, S. J. Original antigenic sin: experiments with a defined antigen. Mol. Immunol.17, 1539–1544 (1980). ArticleCASPubMed Google Scholar